Find latest Non-Small Cell Lung Cancer videos · 500+ videos
423 views
February 7, 2024
On November 15, 2023, the FDA approved repotrectinib (brand name Augtyro) for locally advanced or metastatic ROS1-positive non-small cell lung cancer.
Comments 0
Login to view comments. Click here to Login